Publicacions en què col·labora amb Rocío Aller de la Fuente (4)

2024

  1. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

    United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1056-1068

2022

  1. Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective

    Seminars in Liver Disease, Vol. 42, Núm. 4, pp. 434-445

  2. Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation

    Scientific Reports, Vol. 12, Núm. 1

2020

  1. Dietary Approach to NAFLD

    Non-Alcoholic Fatty Liver Disease: A 360-degree Overview (Springer International Publishing), pp. 271-287